Cargando…

Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia

Objective: It has been shown that pathogenic variants are associated with poor clinical outcomes in patients with familial hypercholesterolemia (FH). However, data on the effect of different types of pathogenic variants on FH phenotype is limited. Methods: We retrospectively investigated the associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Hayato, Kojima, Nobuko, Yamagami, Kan, Nomura, Akihiro, Nohara, Atsushi, Usui, Soichiro, Sakata, Kenji, Fujino, Noboru, Takamura, Masayuki, Kawashiri, Masa-Aki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035489/
https://www.ncbi.nlm.nih.gov/pubmed/35480308
http://dx.doi.org/10.3389/fgene.2022.872056
_version_ 1784693302405103616
author Tada, Hayato
Kojima, Nobuko
Yamagami, Kan
Nomura, Akihiro
Nohara, Atsushi
Usui, Soichiro
Sakata, Kenji
Fujino, Noboru
Takamura, Masayuki
Kawashiri, Masa-Aki
author_facet Tada, Hayato
Kojima, Nobuko
Yamagami, Kan
Nomura, Akihiro
Nohara, Atsushi
Usui, Soichiro
Sakata, Kenji
Fujino, Noboru
Takamura, Masayuki
Kawashiri, Masa-Aki
author_sort Tada, Hayato
collection PubMed
description Objective: It has been shown that pathogenic variants are associated with poor clinical outcomes in patients with familial hypercholesterolemia (FH). However, data on the effect of different types of pathogenic variants on FH phenotype is limited. Methods: We retrospectively investigated the associations between genotypes and phenotypes, including low-density lipoprotein (LDL) cholesterol level and the occurrence of major adverse cardiac events (MACEs), defined as cardiovascular death, myocardial infarction, unstable angina, or coronary artery revascularization, in patients with FH (N = 1,050, male/female = 490/560). Based on genotype, the patients were divided into the following three groups: patients without pathogenic variants, patients with missense variants, and patients with protein-truncating variants (PTVs). Cox proportional hazard model was used to identify the factors associated with MACEs. Results: The median follow-up duration was 12.6 years (interquartile range = 9.5–17.9 years). There were 665 patients with FH-mutation (277 patients with missense variants and 388 patients with PTVs) and 385 patients without FH-mutation. Over the follow-up duration, 175 MACEs were observed. We identified 89 different pathogenic variants in the 665 patients with FH. LDL cholesterol level was found to be significantly higher in patients with PTVs (256 mg/dl) than in patients with missense variants (236 mg/dl) and patients without pathogenic variants (216 mg/dl). It was also found that PTVs and missense variants are significantly associated with MACEs (hazard ratio [HR] = 1.58, 95% confidence interval [CI] = 1.08–2.08, p = 0.0033 and HR = 3.24, 95% CI = 2.12–4.40, p = 3.9 × 10(−6), respectively), independent of classical risk factors. Conclusion: Pathogenic variants, especially PTVs, are significantly associated with poor outcomes in patients with FH. Genetic testing is useful for the diagnosis and risk stratification of patients with FH.
format Online
Article
Text
id pubmed-9035489
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90354892022-04-26 Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia Tada, Hayato Kojima, Nobuko Yamagami, Kan Nomura, Akihiro Nohara, Atsushi Usui, Soichiro Sakata, Kenji Fujino, Noboru Takamura, Masayuki Kawashiri, Masa-Aki Front Genet Genetics Objective: It has been shown that pathogenic variants are associated with poor clinical outcomes in patients with familial hypercholesterolemia (FH). However, data on the effect of different types of pathogenic variants on FH phenotype is limited. Methods: We retrospectively investigated the associations between genotypes and phenotypes, including low-density lipoprotein (LDL) cholesterol level and the occurrence of major adverse cardiac events (MACEs), defined as cardiovascular death, myocardial infarction, unstable angina, or coronary artery revascularization, in patients with FH (N = 1,050, male/female = 490/560). Based on genotype, the patients were divided into the following three groups: patients without pathogenic variants, patients with missense variants, and patients with protein-truncating variants (PTVs). Cox proportional hazard model was used to identify the factors associated with MACEs. Results: The median follow-up duration was 12.6 years (interquartile range = 9.5–17.9 years). There were 665 patients with FH-mutation (277 patients with missense variants and 388 patients with PTVs) and 385 patients without FH-mutation. Over the follow-up duration, 175 MACEs were observed. We identified 89 different pathogenic variants in the 665 patients with FH. LDL cholesterol level was found to be significantly higher in patients with PTVs (256 mg/dl) than in patients with missense variants (236 mg/dl) and patients without pathogenic variants (216 mg/dl). It was also found that PTVs and missense variants are significantly associated with MACEs (hazard ratio [HR] = 1.58, 95% confidence interval [CI] = 1.08–2.08, p = 0.0033 and HR = 3.24, 95% CI = 2.12–4.40, p = 3.9 × 10(−6), respectively), independent of classical risk factors. Conclusion: Pathogenic variants, especially PTVs, are significantly associated with poor outcomes in patients with FH. Genetic testing is useful for the diagnosis and risk stratification of patients with FH. Frontiers Media S.A. 2022-04-11 /pmc/articles/PMC9035489/ /pubmed/35480308 http://dx.doi.org/10.3389/fgene.2022.872056 Text en Copyright © 2022 Tada, Kojima, Yamagami, Nomura, Nohara, Usui, Sakata, Fujino, Takamura and Kawashiri. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Tada, Hayato
Kojima, Nobuko
Yamagami, Kan
Nomura, Akihiro
Nohara, Atsushi
Usui, Soichiro
Sakata, Kenji
Fujino, Noboru
Takamura, Masayuki
Kawashiri, Masa-Aki
Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
title Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
title_full Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
title_fullStr Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
title_full_unstemmed Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
title_short Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
title_sort effects of different types of pathogenic variants on phenotypes of familial hypercholesterolemia
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035489/
https://www.ncbi.nlm.nih.gov/pubmed/35480308
http://dx.doi.org/10.3389/fgene.2022.872056
work_keys_str_mv AT tadahayato effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia
AT kojimanobuko effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia
AT yamagamikan effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia
AT nomuraakihiro effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia
AT noharaatsushi effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia
AT usuisoichiro effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia
AT sakatakenji effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia
AT fujinonoboru effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia
AT takamuramasayuki effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia
AT kawashirimasaaki effectsofdifferenttypesofpathogenicvariantsonphenotypesoffamilialhypercholesterolemia